Comprehensive genomic access to vector integration in clinical gene therapy-Reference-Cited by-同舟云学术

Comprehensive genomic access to vector integration in clinical gene therapy

Published:2009-11-22 Issue:12 Volume:15 Page:1431-1436
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Gabriel Richard,Eckenberg Ralph,Paruzynski Anna,Bartholomae Cynthia C,Nowrouzi Ali,Arens Anne,Howe Steven J,Recchia Alessandra,Cattoglio Claudia,Wang Wei,Faber Katrin,Schwarzwaelder Kerstin,Kirsten Romy,Deichmann Annette,Ball Claudia R,Balaggan Kamaljit S,Yáñez-Muñoz Rafael J,Ali Robin R,Gaspar H Bobby,Biasco Luca,Aiuti Alessandro,Cesana Daniela,Montini Eugenio,Naldini Luigi,Cohen-Haguenauer Odile,Mavilio Fulvio,Thrasher Adrian J,Glimm Hanno,von Kalle Christof,Saurin William,Schmidt Manfred

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2057.pdf

Reference28 articles.

1. Aiuti, A. et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296, 2410–2413 (2002).

2. Cavazzana-Calvo, M. et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669–672 (2000).

3. Flotte, T.R. Gene therapy: the first two decades and the current state-of-the-art. J. Cell. Physiol. 213, 301–305 (2007).

4. Gaspar, H.B. et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364, 2181–2187 (2004).

5. Hacein-Bey-Abina, S. et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415–419 (2003).

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article;Human Gene Therapy;2024-08-01

2. Prenatal AAV9-GFP administration in fetal lambs results in transduction of female germ cells and maternal exposure to virus;Molecular Therapy - Methods & Clinical Development;2024-06

3. Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma;Nature Communications;2024-01-08

4. Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying Rag1 hypomorphic mutations;Frontiers in Immunology;2023-11-13

5. Improved transformation efficiency in Mycoplasma hominis enables disruption of the MIB–MIP system targeting human immunoglobulins;Microbiology Spectrum;2023-10-17